Detalhe da pesquisa
1.
VEXAS syndrome: A review of bone marrow aspirate and biopsies reporting myeloid and erythroid precursor vacuolation.
Eur J Haematol
; 110(6): 633-638, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788756
2.
Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis.
Haematologica
; 102(2): 327-335, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27789678
3.
Improved survival in red blood cell transfusion dependent patients with primary myelofibrosis (PMF) receiving iron chelation therapy.
Hematol Oncol
; 28(1): 40-8, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19557769
4.
Published guidelines versus real-life practice in the diagnosis and treatment of essential thrombocythemia.
Am J Hematol
; 86(9): 792-4, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21805495
5.
Improved survival with iron chelation therapy for red blood cell transfusion dependent lower IPSS risk MDS may be more significant in patients with a non-RARS diagnosis.
Leuk Res
; 36(11): 1380-6, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22921191
6.
Clinical Features, Treatment, and Outcome of HIV-Associated Immune Thrombocytopenia in the HAART Era.
Adv Hematol
; 2012: 910954, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22693513
7.
Hodgkin's lymphoma in adolescents.
J Clin Oncol
; 24(16): 2520-6, 2006 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16735704
8.
Recognition and management of methemoglobinemia and hemolysis in a G6PD-deficient patient on experimental anticancer drug Triapine.
Am J Hematol
; 81(3): 210-1, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16493607